Enhanced insulin sensitivity in mice lacking ganglioside GM3
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Gangliosides are sialic acid-containing glycosphingolipids that are present on all mammalian plasma membranes where they participate in recognition and signaling activities. We have established mutant mice that lack GM3 synthase (CMP-NeuAc:lactosylceramide α2,3-sialyltransferase; EC 2.4.99.-). These mutant mice were unable to synthesize GM3 ganglioside, a simple and widely distributed glycosphingolipid. The mutant mice were viable and appeared without major abnormalities but showed a heightened sensitivity to insulin. A basis for the increased insulin sensitivity in the mutant mice was found to be enhanced insulin receptor phosphorylation in skeletal muscle. Importantly, the mutant mice were protected from high-fat diet-induced insulin resistance. Our results show that GM3 ganglioside is a negative regulator of insulin signaling, making it a potential therapeutic target in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [405]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,942
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 718
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692
Hakomori, S.-I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012540899 · Cited by 492
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Self-citation
Cited by
Items 201–300 of 573
Insulin Resistance as a Membrane Microdomain Disorder
Inokuchi, J. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1532 · Cited by 50
Serlie, M. J., Meijer, A. J., Groener, J. E., Duran, M., Endert, E., Fliers, E., Aerts, J. M., & Sauerwein, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2347 · Cited by 49
Conditional LoxP‐flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis
Yamashita, T., Allende, M. L., Kalkofen, D. N., Werth, N., Sandhoff, K., & Proia, R. L. (2005) · genesis · doi:10.1002/gene.20167 · Cited by 41
Self-citationSonnino, S., Aureli, M., Loberto, N., Chigorno, V., & Prinetti, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.020 · Cited by 44
Uemura, S., Yoshida, S., Shishido, F., & Inokuchi, J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1219 · Cited by 49
Setshedi, M., Longato, L., Petersen, D. R., Ronis, M., Chen, W. C., Wands, J. R., & de la Monte, S. M. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01569.x · Cited by 48
Hepatic Glycosphingolipid Deficiency and Liver Function in Mice
Jennemann, R., Rothermel, U., Wang, S., Sandhoff, R., Kaden, S., Out, R., van Berkel, T. J. C., Aerts, J. M. F. G., der Vlugt, K. G., Sticht, C., et al. (2010) · Hepatology · doi:10.1002/hep.23545 · Cited by 48
Self-citationGanglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts
Liu, Y., Su, Y., Wiznitzer, M., Epifano, O., & Ladisch, S. (2008) · Glycobiology · doi:10.1093/glycob/cwn039 · Cited by 48
Dam, D. H. M., Wang, X.-Q., Sheu, S. L., Vijay, M., Shipp, D. M., Miller, L., & Paller, A. S. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.028 · Cited by 47
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation
Trinchera, M., Parini, R., Indellicato, R., Domenighini, R., & Dall’Olio, F. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.06.014 · Cited by 47
Ceramide and Sphingosine 1-Phosphate in Liver Diseases.
Park, W., Song, J.-H., Kim, G., & Park, T. (2020) · PubMed Central · doi:10.14348/molcells.2020.0054 · Cited by 47
Gangliosides help stabilize the brain
Proia, R. L. (2004) · Nature Genetics · doi:10.1038/ng1104-1147 · Cited by 47
Self-citationGolgi Apparatus Regulates Plasma Membrane Composition and Function
Agliarulo, I., & Parashuraman, S. (2022) · Cells · doi:10.3390/cells11030368 · Cited by 46
Wentworth, J. M., Naselli, G., Ngui, K., Smyth, G. K., Liu, R., O’Brien, P. E., Bruce, C. R., Weir, J. M., Cinel, M. A., Meikle, P. J., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.223 · Cited by 46
Gangliosides in nervous system development, regeneration, and pathologies
Vasques, J. F., Gonçalves, R. G. D. J., da Silva‐Junior, A. J., Martins, R. S., Gubert, F., & Méndez‐Otero, R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343890 · Cited by 44
Miyagi, T., & Yamaguchi, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00055-6 · Cited by 47
Physiopathological function of hematoside (GM3 ganglioside)
Inokuchi, J. (2011) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.87.179 · Cited by 43
Bhuiyan, R. H., Ohmi, Y., Ohkawa, Y., Zhang, P., Takano, M., Hashimoto, N., Okajima, T., Furukawa, K., & Furukawa, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.034 · Cited by 43
Congenital Disorders of Ganglioside Biosynthesis
Li, T. A., & Schnaar, R. L. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.001 · Cited by 43
Glycosphingolipids in signaling and development: From liposomes to model organisms
Pontier, S. M., & Schweisguth, F. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22766 · Cited by 42
Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3
Nagafuku, M., Sato, T., Sato, S., Shimizu, K., Taira, T., & Inokuchi, J. (2014) · Glycobiology · doi:10.1093/glycob/cwu112 · Cited by 42
Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease
Shayman, J. A. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.007 · Cited by 42
Human genetic disorders of sphingolipid biosynthesis
Astudillo, L. M., Sabourdy, F., Therville, N., Bode, H., Ségui, B., Andrieu‐Abadie, N., Hornemann, T., & Levade, T. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9736-1 · Cited by 42
The Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance
Straczkowski, M., & Kowalska, I. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.13 · Cited by 41
Indellicato, R., Parini, R., Domenighini, R., Malagolini, N., Iascone, M. R., Gasperini, S., Masera, N., Dall’Olio, F., & Trinchera, M. (2018) · Glycobiology · doi:10.1093/glycob/cwy112 · Cited by 41
Glycosphingolipids and Kidney Disease
Mather, A. R., & Siskind, L. J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_8 · Cited by 41
Defining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 41
Sphingolipids as Biomarkers of Disease
Matanes, F., Twal, W. O., & Hammad, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_7 · Cited by 40
Homeostatic and pathogenic roles of the GM3 ganglioside
Inokuchi, J., Kanoh, H., Inamori, K., Nagafuku, M., Nitta, T., & Fukase, K. (2021) · FEBS Journal · doi:10.1111/febs.16076 · Cited by 41
Monogenic neurological disorders of sphingolipid metabolism
Sabourdy, F., Astudillo, L. M., Colacios, C., Dubot, P., Mrad, M., Ségui, B., Andrieu‐Abadie, N., & Levade, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.010 · Cited by 39
Jiang, X., & Li, Z. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_1 · Cited by 39
Molecular simulations of glycolipids: Towards mammalian cell membrane models
Shorthouse, D., Hedger, G., Koldsø, H., & Sansom, M. S. P. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.033 · Cited by 39
Shayman, J. A. (2013) · Europe PMC (PubMed Central) · Cited by 39
Hashiramoto, A., 酒井千菜, Yoshida, K., Tsumiyama, K., Miura, Y., Shiozawa, K., Nose, M., Komai, K., & Shiozawa, S. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22727 · Cited by 39
Self-citationTorres, M., Rosselló, C. A., Fernández‐García, P., Lladó, V., Kakhlon, O., & Escribá, P. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072322 · Cited by 38
Kim, S.-J., Chung, T., Choi, H.-J., Kwak, C.-H., Song, K., Suh, S., Kwon, K., Chang, Y., Park, Y., Chang, H. W., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120189 · Cited by 38
Indellicato, R., & Trinchera, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133304 · Cited by 38
Rawat, S. S., Gallo, S. A., Eaton, J., Martin, T. D., Ablan, S. D., KewalRamani, V. N., Wang, J., Blumenthal, R., & Puri, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7360-7368.2004 · Cited by 38
Ogiso, H., Taniguchi, M., Araya, S., Aoki, S., Wardhani, L. O., Yamashita, Y. I., Ueda, Y., & Okazaki, T. (2014) · Metabolites · doi:10.3390/metabo4010098 · Cited by 37
Depletion of gangliosides enhances cartilage degradation in mice
Sasazawa, F., Onodera, T., Yamashita, T., Seito, N., Tsukuda, Y., Fujitani, N., Shinohara, Y., & Iwasaki, N. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.11.015 · Cited by 37
Self-citationKovács, T., Zákány, F., & Nagy, P. (2022) · Cancers · doi:10.3390/cancers14040944 · Cited by 37
Zarini, S., Brozinick, J. T., Berry, K. A. Z., Garfield, A., Perreault, L., Kerege, A. A., Bui, H. H., Sanders, P., Siddall, P., Kuo, M. S., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100270 · Cited by 38
Glycosphingolipids in the Regulation of the Nervous System
Furukawa, K., Ohmi, Y., Ohkawa, Y., Tajima, O., & Furukawa, K. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_14 · Cited by 37
The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain
Sims-Robinson, C., Bakeman, A., Rosko, A., Glasser, R., & Feldman, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9207-1 · Cited by 31
GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment
Büschenfelde, C. M. Z., Feuerstacke, Y., Götze, K. S. S., Scholze, K., & Peschel, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5601 · Cited by 37
Ganglioside Metabolism and Its Inherited Diseases
Breiden, B., & Sandhoff, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8552-4_5 · Cited by 37
Self-citationNatoli, T. A., Husson, H., Rogers, K. A., Smith, L. A., Wang, B., Budman, Y., Bukanov, N. O., Ledbetter, S. R., Klinger, K. W., Leonard, J. P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds172 · Cited by 36
Functional Diversity of Mammalian Sialyltransferases
Takashima, S., & Tsuji, S. (2011) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.23.178 · Cited by 36
Self-citationMice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
Lopez, P. H., Aja, S. M., Aoki, K., Seldin, M. M., Lei, X., Ronnett, G. V., Wong, G. W., & Schnaar, R. L. (2016) · Glycobiology · doi:10.1093/glycob/cww098 · Cited by 36
Gangliosides in Axon Stability and Regeneration
López, P. H. H., & Báez, B. B. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.03.001 · Cited by 36
Glycosphingolipids in endocytic membrane transport
Sillence, D. J., & Platt, F. M. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.03.004 · Cited by 36
Liu, Y., Yan, S., Wondimu, A., Bob, D., Weiss, M., Sliwinski, K., Villar, J., Notario, V., Sutherland, M. L., Colberg‐Poley, A. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.85 · Cited by 35
Zhang, S., Berntsson, R. P. ‐., Tepp, W. H., Tao, L., Johnson, E. A., Stenmark, P., & Dong, M. (2017) · Nature Communications · doi:10.1038/s41467-017-01534-z · Cited by 35
Sphingolipids and membrane biology as determined from genetic models
Rao, R. P., & Acharya, J. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.10.002 · Cited by 35
Insulin Resistance as a Membrane Microdomain Disorder
Inokuchi, J. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.579 · Cited by 35
Masson, E., Troncy, L., Ruggiero-Lopez, D., Wiernsperger, N. F., Lagarde, M., & Bawab, S. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.220 · Cited by 35
The Glycosphingolipid GM3 Modulates Conformational Dynamics of the Glucagon Receptor
Ansell, T. B., Song, W., & Sansom, M. S. P. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.06.009 · Cited by 34
Balram, A., Thapa, S., & Chatterjee, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315442 · Cited by 34
Therapeutic Strategies for Diabetes and Complications: A Role for Sphingolipids?
Fox, T. E., & KESTER, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_14 · Cited by 34
N-Azidoacetylmannosamine-mediated chemical tagging of gangliosides
Bussink, A. P., van Swieten, P. F., der Vlugt, K. G., Scheij, S. S., van Eijk, M., Wennekes, T., van der MAREL, G. A., Boot, R. G., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.c700006-jlr200 · Cited by 34
Zebrafish and Mouse α2,3-Sialyltransferases Responsible for Synthesizing GM4 Ganglioside
Chisada, S., Yoshimura, Y., Sakaguchi, K., Uemura, S., Go, S., Ikeda, K., Uchima, H., Matsunaga, N., Ogura, K., Tai, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016188 · Cited by 34
Kurz, E., Chen, S., Vucic, E., Baptiste, G. G., Loomis, C. A., Agrawal, P. K., Hajdu, C. H., Bar‐Sagi, D., & Mahal, L. K. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100160 · Cited by 33
Kármán, J., Tedstone, J. L., Gumlaw, N., Zhu, Y., Yew, N. S., Siegel, C., Guo, S., Siwkowski, A., Ruzek, M. C., Jiang, C., et al. (2010) · International Immunology · doi:10.1093/intimm/dxq044 · Cited by 33
Organization and function of glycosphingolipids in membrane
Hakomori, S. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.189 · Cited by 33
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
Herzer, S., Meldner, S., Rehder, K., Gröne, H.-J., & Nordström, V. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0354-z · Cited by 32
Lipid mediators of insulin signaling in diabetic kidney disease
Mitrofanova, A. V., Sosa, M. A., & Fornoni, A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00379.2019 · Cited by 32
Kuan, C., Chang, J., Månsson, J., Li, J., Pegram, C. N., Fredman, P., McLendon, R. E., & Bigner, D. D. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-114 · Cited by 32
Implications for the mammalian sialidases in the physiopathology of skeletal muscle
Fanzani, A., Zanola, A., Faggi, F., Papini, N., Venerando, B., Tettamanti, G., Sampaolesi, M., & Monti, E. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-23 · Cited by 32
Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
Jennemann, R., Federico, G., Mathow, D., Rabionet, M., Rampoldi, F., Popović, Z. V., Volz, M., Hielscher, T., Sandhoff, R., & Gröne, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22648 · Cited by 32
Self-citationZurita, A. R., Crespo, P. M., Koritschoner, N. P., & Daniotti, J. L. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04165.x · Cited by 32
Self-citationYang, J., Zhang, T., Dong, Z., Shi, H.-H., Xu, J., Mao, X., Wang, Y.-M., & Xue, C. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06831 · Cited by 31
Paget, C., Deng, S., Soulard, D., Priestman, D. A., Speca, S., von Gerichten, J., Speak, A. O., Saroha, A., Pewzner‐Jung, Y., Futerman, A. H., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000169 · Cited by 31
Self-citationGlycosphingolipide – Natur, Funktion und pharmakologische Modulierung
Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G. (2009) · Angewandte Chemie · doi:10.1002/ange.200902620 · Cited by 30
Organization of gangliosides into membrane nanodomains
Sarmento, M. J., Ricardo, J. C., Amaro, M., & Šachl, R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13871 · Cited by 30
Glycosphingolipid Disorders of the Brain
Boomkamp, S. D., & Butters, T. D. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_17 · Cited by 30
Sulfatides Partition Disabled-2 in Response to Platelet Activation
Drahos, K. E., Welsh, J. D., Finkielstein, C. V., & Capelluto, D. G. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008007 · Cited by 30
Synthesis and characterization of some atypical sphingoid bases
Saied, E. M., Le, T. L.-S., Hornemann, T., & Arenz, C. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.06.031 · Cited by 29
Roles for Golgi Glycans in Oogenesis and Spermatogenesis
Akintayo, A., & Stanley, P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00098 · Cited by 29
Uemura, S., Go, S., Shishido, F., & Inokuchi, J. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-013-9499-1 · Cited by 28
Herzer, S., Meldner, S., Gröne, H., & Nordström, V. (2015) · Diabetes · doi:10.2337/db14-1726 · Cited by 28
Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts
Shevchuk, N. A., Hathout, Y., Epifano, O., Su, Y., Liu, Y., Sutherland, M. L., & Ladisch, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.008 · Cited by 28
Serlie, M. J. M., Allick, G., Groener, J. E. M., Ackermans, M. T., Heijligenberg, R., Voermans, B. C., Aerts, J. M. F. G., Meijer, A. J., & Sauerwein, H. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1518 · Cited by 28
Hülsmeier, A. J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106851 · Cited by 27
Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease
Paccalet, T., Coulombe, Z., & Tremblay, J. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010055 · Cited by 27
Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders
Magnan, C., & Stunff, H. L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101298 · Cited by 27
Carobbio, S., Pellegrinelli, V., & Vidal‐Puig, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_8 · Cited by 26
Shui, G., Lam, S. M., Stebbins, J. W., Kusunoki, J., Duan, X., Li, B., Cheong, W. F., Soon, D., Kelly, R. P., & Wenk, M. R. (2013) · Metabolomics · doi:10.1007/s11306-013-0494-0 · Cited by 26
Inamori, K., Ito, H., Tamura, Y., Nitta, T., Yang, X., Nihei, W., Shishido, F., Imazu, S., Tsukita, S., Yamada, T., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085753 · Cited by 26
Shimizu, T., Nagane, M., Suzuki, M., Yamauchi, A., Kato, K., Kawashima, N., Nemoto, Y., Maruo, T., Kawakami, Y., & Yamashita, T. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129723 · Cited by 26
Self-citationStrekalova, T. V., Svirin, E. P., Veniaminova, E. A., Kopeikina, E., Veremeyko, T., Yung, A. W. Y., Proshin, A. T., Walitza, S., Anthony, D. C., Lim, L. W., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100306 · Cited by 26
Menichella, D. M., Jayaraj, N. D., Wilson, H. M., Ren, D., Flood, K. S., Wang, X.-Q., Shum, A. K., Miller, R. J., & Paller, A. S. (2016) · Molecular Pain · doi:10.1177/1744806916666284 · Cited by 26
Li, H., Turley, S. D., Liu, B., Repa, J. J., & Dietschy, J. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800180-jlr200 · Cited by 26
Unique Biological Activity of Botulinum D/C Mosaic Neurotoxin in Murine Species
Nakamura, K., Kohda, T., Shibata, Y., Tsukamoto, K., Arimitsu, H., Hayashi, M., Mukamoto, M., Sasakawa, N., & Kozaki, S. (2012) · Infection and Immunity · doi:10.1128/iai.00302-12 · Cited by 26
Discovery and Characterization of an Inhibitor of Glucosylceramide Synthase
Richards, S. J., Larson, C. J., Koltun, E. S., Hanel, A., Chan, V., Nachtigall, J., Harrison, A., Aay, N., Du, H., Arcalas, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300122u · Cited by 25
Iwamori, M., & Iwamori, Y. (2005) · Glycoconjugate Journal · doi:10.1007/s10719-005-0363-9 · Cited by 25
Ahonen, M. A., Höring, M., Nguyen, V. D., Qadri, S. U., Taskinen, J., Nagaraj, M., Wabitsch, M., Fischer‐Posovszky, P., Zhou, Y., Liebisch, G., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00496-3 · Cited by 24
Obesity causes a shift in metabolic flow of gangliosides in adipose tissues
Tanabe, A., Matsuda, M., Fukuhara, A., Miyata, Y., Komuro, R., Shimomura, I., & Tojo, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.086 · Cited by 24
Phenotype of ST3GAL3 deficient patients: A case and review of the literature
Khamirani, H. J., Zoghi, S., Faghihi, F., Dastgheib, S. A., Hassanipour, H., Tabei, K., Mohammadi, S., Masoudi, M., Poorang, S., Ehsani, E., et al. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104250 · Cited by 24
van Diepen, L., Buettner, F. F. R., Hoffmann, D., Thiesler, C. T., Halbach, O. V. B. U., Halbach, V. V. B. U., Jensen, L. R., Steinemann, D., Edvardson, S., Elpeleg, O. N., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0220-5 · Cited by 24
Montgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Anari, M., Taddese, A. Z., Williamson, N. A., Ooi, G., Brown, W. A., et al. (2022) · Diabetes · doi:10.2337/db22-0590 · Cited by 23
Metadata
- Authors
- Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L.
- Affiliations
- National Institutes of Health (US)
- Genetics of Development and Disease and Diabetes Branches, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Molecular Glycobiology, The Glycoscience Institute, Ochanomizu University, Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; Centro de Investigaciones en Quimica Biologica de Cordoba, Departamento de Quimica Biologica, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Ciudad Universitaria, 5000 Cordoba, Argentina; Kekulé...
- Corresponding author
- Proia, Richard L.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-10
- Volume
- 100
- Issue
- 6
- Pages
- 3445-3449
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC152312
- OpenAlex
- W2032416398
- Cited by
- 531
- References
- 20
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 12 · 2023: 16 · 2022: 29 · 2021: 16 · 2020: 31 · 2019: 22 · 2018: 24 · 2017: 18 · 2016: 23 · 2015: 22 · 2014: 28 · 2013: 29 · 2012: 31
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- GM3 ganglioside, GM3 synthase, insulin sensitivity, insulin resistance, insulin receptor phosphorylation, skeletal muscle, high-fat diet, type 2 diabetes, glycosphingolipids, sialic acid, mouse mutants
- MeSH terms
- Animals, Dietary Fats, G(M3) Ganglioside, Insulin Resistance, Mice, Inbred C57BL, Phosphorylation, Receptor, Insulin, Sialyltransferases, Signal Transduction, Mice, Knockout, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.